Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
2017 · Hepatology · 268 citations
https://doi.org/10.1002/hep.29676
P
Peng Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
193
Papers
6.6K
Citations
37
h-index
82
i10-index
Peng Chen is an academic researcher from Qingdao University. The author has contributed to research in topics: Gut microbiota and health & Liver Disease Diagnosis and Treatment & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 37, co-authored 165 publications.
ORCID: 0000-0003-0473-205XPapers by this author
worksHyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
2023 · Cell Metabolism · 253 citations
https://doi.org/10.1016/j.cmet.2023.07.011
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
2019 · Signal Transduction and Targeted Therapy · 240 citations
https://doi.org/10.1038/s41392-019-0074-5
Novel tripeptide RKH derived from <i>Akkermansia muciniphila</i> protects against lethal sepsis
2023 · Gut · 98 citations
https://doi.org/10.1136/gutjnl-2023-329996
Acetate reprograms gut microbiota during alcohol consumption
2022 · Nature Communications · 90 citations
https://doi.org/10.1038/s41467-022-31973-2
Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis
2023 · Molecular Therapy · 68 citations
https://doi.org/10.1016/j.ymthe.2023.01.018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat